Top Sell
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.40 | - | - |
| Abeona Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.14 | €33.73 | 974.153% |
| Novan Inc | 0 | 24 | 0 | 1 | €0.001 | - | - |
| Nymox Pharmaceutical Corp. | 0 | 3 | 0 | 0 | €0.23 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.00 | €3.65 | 265.998% |
| scPharmaceuticals | 3 | 1 | 0 | 0 | €4.02 | €16.43 | 308.716% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 0 | €0.93 | - | - |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €29.75 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.38 | €7.00 | 194.118% |
| Formycon AG | 3 | 1 | 0 | 0 | €39.95 | €100.00 | 150.313% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 0 | €1.35 | €5.10 | 278.019% |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.69 | €1.20 | -28.994% |
| Neptune Wellness Solutions Inc | 0 | 14 | 0 | 0 | €0.14 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.86 | €3.00 | 61.290% |
| Trevena Inc. | 1 | 13 | 0 | 0 | €0.33 | €8.37 | 2474.277% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €31.40 | €50.00 | 59.236% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.84 | €5.51 | 554.941% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.30 | €0.000 | -100.000% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.46 | €18.30 | 1149.727% |
| T2 Biosystems Inc. | 0 | 13 | 0 | 0 | €0.16 | - | - |
| Medigene AG | 0 | 2 | 0 | 0 | €1.58 | €1.00 | -36.709% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Sangamo Therapeutics Inc. | 11 | 12 | 0 | 0 | €0.49 | €2.79 | 466.599% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.98 | - | - |
| Adaptimmune Therapeutics PLC ADR | 1 | 2 | 0 | 0 | €0.99 | €1.25 | 26.263% |